| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.41 | 0.01 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.39 | 0.01 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |